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Abstract: 
 
Natural phytochemicals derived from dietary sources or medicinal plants have gained significant 
recognition in the potential management of several human clinical conditions. Much research has 
also been geared towards the evaluation of plant extracts as effective prophylactic agents since 
they can act on specific and/or multiple molecular and cellular targets. Plants have been an 
abundant source of highly effective phytochemicals which offer great potential in the fight 
against cancer by inhibiting the process of carcinogenesis through the upregulation of 
cytoprotective genes that encode for carcinogen detoxifying enzymes and antioxidant enzymes. 
The mechanistic insight into chemoprevention further includes induction of cell cycle arrest and 
apoptosis or inhibition of signal transduction pathways mainly the mitogen-activated protein 
kinases (MAPK), protein kinases C (PKC), phosphoinositide 3-kinase (PI3K), glycogen synthase 
kinase (GSK) which lead to abnormal cyclooxygenase-2 (COX-2), activator protein-1 (AP-1), 
nuclear factor-kappaB (NF-κB) and c-myc expression. Effectiveness of chemopreventive agents 
reflects their ability to counteract certain upstream signals that leads to genotoxic damage, redox 
imbalances and other forms of cellular stress. Targeting malfunctioning molecules along the 
disrupted signal transduction pathway in cancer represent a rational strategy in chemoprevention. 
NF-κB and AP-1 provide mechanistic links between inflammation and cancer, and moreover 
regulate tumor angiogenesis and invasiveness, indicating that signaling pathways that mediate 
their activation provide attractive targets for new chemotherapeutic approaches. Thus cell 
signaling cascades and their interacting factors have become important targets of 
chemoprevention and phenolic phytochemicals and plant extracts seem to be promising in this 
endeavor. 
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Article: 
 
1. Introduction 
 
Cancer development is a multifactorial and multistage process consisting of three distinct phases: 
initiation, promotion and progression phases. Epigenetic changes in particular, aberrant promoter 
hypermethylation associated with inappropriate gene silencing contribute significantly to the 
initiation and progression of human cancer (Jones and Baylin, 2002). While current clinical 
therapies including radiation, chemotherapy, immunosuppression and surgery are limited as 
indicated by the high morbidity and mortality rate from cancer, there is an imperative need for 
new treatment modalities. Chemoprevention which involves the use of pharmacological, dietary 
biofactors, phytochemicals and even whole plant extracts to prevent, arrest or reverse the cellular 
and molecular processes of carcinogenesis has been proposed due to its multiple intervention 
strategies. In addition, epidemiological and experimental studies highlight the protective roles of 
dietary phytochemicals including sulforaphane, resveratrol, genistein, curcumin, 
epigallocatechin-3-gallate (EGCG), gingerol, diallyl sulfide, brassinin and caffeic acid phenyl 
ester for the control and containment of carcinogenesis (Arai et al., 2000, Bettuzzi et al., 
2006, Chan et al., 2009, Kale et al., 2008, Knekt et al., 1997, Kundu and Surh, 2005, Surh, 
2003). Plant-derived phytochemicals as well have played a dominant therapeutic role in the 
treatment of human ailments and plant extracts continue to play a major role in all forms of 
modern day pharmaceutical care. Research has also been directed towards the use of total plant 
extracts mainly because of the synergistic effects of the cocktail of plant metabolites and the 
multiple points of intervention in chemoprevention. The preventive mechanisms of tumor 
promotion by natural phytochemicals range from the inhibition of genotoxic effects, increased 
antioxidant and anti-inflammatory activity, inhibition of proteases and cell proliferation, 
protection of intercellular communications to modulation of apoptosis and signal transduction 
pathways (Chen and Kong, 2005, De Flora and Ferguson, 2005, Holmes-McNary and Baldwin, 
2000, Hwang et al., 2005, Shimizu et al., 2005, Yu and Kensler, 2005, Aruoma et al., 2005, 
Soobrattee et al., 2006). However, well-controlled randomized clinical trials are warranted to 
ascertain the chemopreventive efficacy of these phytochemicals. Recent progress in 
understanding the molecular changes that underlie cancer development offer the prospect of 
specifically targeting malfunctioning molecules and pathways to achieve more effective and 
rational cancer therapy. This paper reviews the potential targets of chemoprevention and also 
emphasizes the important role of plant extracts and plant-derived phytochemicals primarily of 
polyphenolics in targeting disrupted cell signaling transduction pathways in carcinogenesis. 
 
1.1. Regulation of nuclear factor-E2 related factor 2 (Nrf2) via the antioxidant/electrophile 
response element (ARE/EpRE) 
 
A successful strategy for halting cancer development is to modulate by pharmacological or 
nutritional means the levels of biotransformation enzymes that promote the elimination of 
endogenous and environmental carcinogens (Owuor and Kong, 2002, Yu and Kensler, 2005). 
Under physiological conditions, these enzymes are expressed constitutively at relatively low 
levels and the expression levels can be enhanced in response to several classes of compounds in 
particular coumarins, diterpenes, indoles, curcumin, sulforaphane, isothiocyanates, (−)-
epigallocatechin gallate and plant extracts in particular Syzygium formosanum and Millettia 
pulchra var microphylla (Chen and Kong, 2004, Chen and Kong, 2005, Kelloff et al., 2000, Lee 
et al., 2006, Na et al., 2008). These compounds can induce the phase I and II detoxifying 
enzymes, however major interest is focused on inducers of phase II detoxifying enzymes for the 
biotransformation and elimination of potential carcinogens. The natural chemopreventive 
compounds serve as transcriptional activators for the expression of glutathione S-transferase, 
NAD(P)H:quinone oxidoreductase (NQO), heme oxygenase 1 (HO 1), γ-glutamylcysteine 
synthetase (γGCS) and antioxidant enzymes via the antioxidant/electrophile response element 
(ARE/EpRE) (Eggler et al., 2008, Owuor and Kong, 2002). The ARE/EpRE has been proposed 
to be pivotal in the regulation of the cellular defense system and has been described as an 
important target for achieving chemoprevention. 
 
The induction effects of phase II detoxifying agents by natural phytochemicals are mediated in 
part through the activation of Nrf2 signaling pathways. Several intracellular signal transduction 
pathways, mitogen-activated protein kinases (MAPKs), protein kinase C (PKC), 
phosphatidylinositol 3-kinase (PI3K) and RNA dependent protein kinase (PKR)-like 
endoplasmic reticulum kinase (PERK) can activate the KEAP 1–Nrf2 complex. Nrf2 interacts 
with KEAP 1, an actin binding cytosolic protein that sequesters the Nrf2 in the cytoplasm and 
targets it for proteasomal degradation. Activation of the KEAP 1–Nrf2 complex leads to the 
release of Nrf2 in the cytosol with the subsequent translocation of the latter to the nucleus which 
results in an increase in the transcriptional activity of ARE-regulated genes (Fig. 1) (Yu and 
Kensler, 2005). Subsequently, Nrf2 heterodimerizes with members of the small Maf protein 
family which bind to the ARE sequence in the promoter regions of many genes encoding 
cytoprotective enzymes. While the mechanism remains unclear how the PI3K signaling 
pathways can activate the KEAP 1–Nrf2 complex, experimental studies have shown that PKC 
and PERK phosphorylate the Ser40 in the KEAP 1-interacting Neh2 domain of the Nrf2 protein 
that results in release of the nuclear factor (Cullinan et al., 2003, Huang et al., 2000, Huang et al., 
2002). MAPKs can affect Nrf2 function through the transcriptional co-activators such as p300, 
peroxisome proliferator-activated receptor (PPAR)-binding protein or cAMP response element-
binding protein (CREB) binding protein (Misra et al., 2002, Shen et al., 2004). 
 
Na et al. (2008) reported the activation of Nrf2 by EGCG in human mammary epithelial cells 
which resulted in the expression of glutamate–cysteine ligase, manganese superoxide dismutase 
and heme oxygenase 1 via the Akt and ERK 1/2 signaling pathways. Gao and Talalay (2004) 
reported the protective effect of sulforaphane against photooxidative damage in retinal pigment 
epithelial cells. The degree of protection was correlated with the potencies of sulforaphane to 
induce and elevate the level of glutathione and NAD(P)H:quinine oxidoreductase. In addition, 
another study indicated the prophylactic effect of sulforaphane via the upregulation of 
thioredoxin in mice retinal pigment epithelial cells (Tanito et al., 2005). The induction of ARE-
dependent genes by chemopreventive phenolic agents including curcumin, isothiocyanates, 
catechins, quercetin has been widely discussed (Ferguson et al., 2004, Khan et al., 1992, Le 
Marchand, 2002, Valerio et al., 2001, Zhang, 2004). Indigenous plants from Taiwan, rich in 
phenolic acid, flavonoids, proanthocyanidins and tannins increased the promoter activity of heme 
oxygenase 1 thus accounting for the cytoprotective effects in rat aortic smooth muscle cells (Lee 
et al., 2006). Owuor and Kong (2002) have indicated that the chemopreventive compounds serve 
as transcriptional activators for the expression of glutathione S-transferase, NAD(P)H:quinone 
oxidoreductase (NQO), heme oxygenase 1 (HO 1), γ-glutamylcysteine synthetase (γGCS) and 
antioxidant enzymes via the antioxidant/electrophile response element (ARE/EpRE). In addition, 
antioxidative enzymes, anti-inflammatory genes and proteasomal subunits can be coordinately 
upregulated via the Nrf2 pathway (Fig. 1). This intricate network of the proteasome system 
functions as the repair machinery that recognizes and degrades damaged proteins which are 
induced by ROS/RNS, thereby limiting the detrimental effects (Davis, 2001, Kwak et al., 2003). 
Nrf2-mediated responses appear to be regulated by multiple kinases, possibly at multiple 
residues of the Nrf2 protein. 
 
 
 
Figure 1. Regulation of the Nrf2-mediated pathways by natural phytochemicals, providing 
multiple modes of resistance to chemical induced carcinogenesis. Nrf2 is thethered in the 
cytoplasm by the KEAP 1 actin binding protein. The function and localization of Nrf2 is 
regulated by multiple upstream kinases (JNK, ERK, PKC, PERK, PI3K). Activation by these 
signaling pathways elicit positive influences on Nrf2 and subsequent translocation to the nucleus 
and binding to ARE sequences in the promoter regions of many genes encoding cytoprotective 
enzymes. 
 
1.2. Targeting the tumor microenvironment: inflammatory mediators and reactive 
oxygen/nitrogen species 
 
Several reports have indicated the intrinsic link between cancer and inflammation (Balkwill and 
Mantovani, 2001, Palapattu et al., 2004, Schwartsburd, 2003). The inflammatory 
microenvironment of tumors is characterized by the presence of tumor-associated macrophages, 
tumor-infiltrating lymphocytes which produces a range of proinflammatory cytokines in 
particular the tumor necrosis factor (TNF), interleukins 1 and 6 (Il-1, Il-6), growth factors, 
chemokines like interleukin 8 (IL-8) and signal transducers and activators of transcription 
(STATs) (Balkwill and Mantovani, 2001, Klampfer, 2008). Cytokines and chemokines can 
promote cancer growth, invasion and metastasis by (i) inducing DNA damage by ROS/RNS, (ii) 
inhibiting the DNA repair mechanisms via ROS/RNS, (iii) the functional inactivation of the 
tumor suppressor genes mainly p53, (iv) autocrine/paracrine growth and survival factors for 
malignant cells, (v) induction of vascular permeability and activation of matrix 
metalloproteinases, (vi) modulation of cell to cell adhesion molecules, (vii) stimulation of 
angiogenesis by favoring the production of angiogenic factors (VEGF, bFGF, IL-8, MMP) 
(Balkwill and Mantovani, 2001, Coussens and Werb, 2002). The significant contribution of 
inflammatory processes in neoplasia has indicated the beneficial role of anti-inflammatory agents 
in cancer prevention. The intake of non-steroidal anti-inflammatory drugs (NSAIDs) correlated 
with a reduced incidence of oesophagus, colon and rectum, stomach cancer (Langman et al., 
2000, Reddy et al., 1996, Steinbach et al., 2000). NSAIDs have shown undisputable promise as 
chemopreventive agents, however major concerns over their cardiovascular toxicity, 
gastrointestinal side effects, liver and renal adverse effects (Bresalier et al., 2005, Gupta and 
Eisen, 2009, Knights et al., 2009, Nussmeier et al., 2005, Solomon et al., 2005, Ulrich et al., 
2006) have shifted interest on natural inflammatory agents that can reverse/and or halt the 
process of carcinogenesis with limited cytotoxicity (Table 2). The implication of inflammatory 
processes and oxidative stress on carcinogenesis indicate the therapeutic benefit of natural anti-
inflammatory agents which exert their activity mostly through the antioxidative property. 
 
Under normal physiological conditions, inflammation is associated with the production of 
diverse free radicals and oxidants that primarily combat and neutralize invading pathogens and 
foreign bodies and also destroy the infected host tissue. However chronic inflammation in cancer 
leads to the continuous production of ROS mainly superoxide radicals (O2 −), hypochlorous acid 
(HOCl), hydrogen peroxide (H2O2), hypobromous acid (HOBr), hydroxyl radicals (OH ) and 
RNS like nitric oxide (NO) and nitrogen dioxide ( NO2) (Ohshima et al., 2005). ROS and RNS 
not only can damage DNA and induce mutations, but also can participate in most carcinogenic 
processes by activating oncogene products and/or inactivating tumor-suppressor proteins 
(Eyfjord and Bodvarsdottir, 2005, Ohshima, 2003). In addition to direct DNA base modifications 
by ROS and RNS, base modifications can be induced by lipid peroxidation end-products 
(malondialdehyde, 4-hydroxynonenal, etc.) to form cyclic adducts (Singer and Bartsch, 1999) 
while lipid peroxides (LOOH) in the presence of heme iron, as in hemoglobin, can also induce 
strand breakage (Sawa et al., 1998) and form abasic sites (Kanazawa et al., 2000). ROS induced 
damage may be targeted towards proteins in the peptide backbone, and in various nucleophilic or 
redox-sensitive side chains (Marnett et al., 2003). Experimental studies have indicated a high 
level of ROS in particular H2O2 in several carcinomas including melanoma, neuroblastoma, 
colon carcinoma, ovarian carcinoma cell lines (Kondo et al., 1999, Toyokuni et al., 1995). The 
H2O2 functions as a signaling molecule triggering signaling events that leads to transcriptional 
activation of cell proliferating genes. Thus an alternative approach is the scavenging of ROS by 
phenolic antioxidants that could short-circuit the signaling events and ultimately the expression 
of responsive genes that stimulate cancer cells. A number of studies have indicated that 
antioxidant rich plant-derived components and extracts can be considered as prophylactic agents 
in cancer. Plant extracts with high antioxidant index can mediate at least in part their 
anticarcinogenic effect by acting as free radical scavengers and metal chelators (Cheung and Tai, 
2007, Ju et al., 2004, Kumar et al., 2007, Lee et al., 2004a, Lee et al., 2004b, Moongkarndi et al., 
2004, Neergheen et al., 2006, Soobrattee et al., 2008) (Table 1). 
 
Table 1. Plant extracts showing high in vitro antioxidant effectiveness as free radical scavengers 
with potentials as anticancer agents. 
Family Plant species Antioxidant activity References 
Asteraceae Baccharis grisebachii Scavenger of superoxide radicals Tapia et al. (2004) 
Campanulaceae Platycodon grandiflorum 
A. De Candolle 
Inhibition of lipid peroxidation and scavenging of DPPH• Lee et al., 2004a, Lee et 
al., 2004b 
Ebenaceae Diospyros mellanida Free radical scavenging activity against hypochlorous 
acid, hydroxyl radical, peroxyl radicals 
Soobrattee et al. (2008) 
Diospyros revaughanii 
 
Diospyros neraudii 
 
Fabaceae Bauhinia racemosa Reduced lipid peroxidation and upregulated the 
antioxidant levels 
Kumar et al. (2007) 
Acacia salicina Scavenger of DPPH• and inhibitor of superoxide radical 
production 
Mansour et al. (2007) 
Lamiaceae Rosmarinus officinalis Showed substantial trolox equivalent antioxidant activity Cheung and Tai (2007) 
Myrtaceae Syzygium commersonii Potent scavenger of hypochlorous acid, hydroxyl radical, 
peroxyl radicals 
Neergheen et al. (2006) 
Syzygium glomeratum 
 
Syzygium mauritianum 
 
Syzygium venosum 
 
Eugenia pollicina 
 
 
Damage to the biomolecules disrupt important metabolic pathways by inducing genetic 
alterations in genes involved in carcinogenesis (e.g. oncogenes and tumor-suppressor genes) or 
by epigenetic processes such as gene methylation, post-translational modifications of proteins 
and modification of gene expression patterns. Post-translational modification of various 
important proteins and enzymes associated with carcinogenesis by ROS and RNS may alter their 
functions (e.g. inhibition of tumor-suppressor gene products such as p53, proapoptotic enzymes 
such as caspases and DNA repair enzymes, etc. and activation of angiogenesis, telomerase, 
COX-2, metalloproteinase, DNA methyltransferase, etc.) (Ohshima et al., 2005). 
 
The anti-inflammatory actions of these compounds can also rest on their ability to inhibit the 
cycloxygenase activity of COX-2 thereby decreasing the production of prostaglandins. COX-2 
overexpression has been found in 90% of colorectal carcinomas and 40% of adenomas (Chapple 
et al., 2000, Eberhart, 1994, Kutchera et al., 1996, Wu, 2005) by possibly intervening through 
several mechanisms (Fig. 2). Prostaglandins in particular PGE2 seems to have a key role in 
carcinogenesis as activation of several types of PGE2 receptors triggers other signaling pathways, 
such as the epidermal growth factor receptor pathway (Han and Wu, 2005, Pai et al., 2002;). 
Furthermore, the genetic or pharmacological disruption of PGE2 receptors reduces tumor 
formation in mouse models of colon carcinogenesis (Mutoh et al., 2002, Watanabe et al., 1999). 
Therefore the suppression of prostaglandin synthesis through selective inhibition of COX-2 is 
another promising strategy in the identification and development of chemopreventive drugs. 
 
 
Figure 2. Key role of COX-2 in tumorigenesis. 
 
A wide array of phenolic substances, particularly those present in dietary and/or medicinal plants 
in particular genistein, gingerol, capsaicin, EGCG, resveratrol and whole plant extracts in 
particular Sutherlandia frutescens, Harpagophytum procumbens and Platycodon grandiflorum 
(Ahn et al., 2005, Cavin et al., 2005, Kundu et al., 2005, Ye et al., 2004) have been reported to 
selectively inhibit the COX 2 expression (Table 1, Table 2). S. fructescens and H. procumbens 
have been shown to inhibit TPA and lipopolysaccharide induced COX-2 expression in human 
mammary epithelial cells and mouse fibroblast L929 cell lines respectively via the inhibition of 
DNA binding of AP-1 and NF-κB (Na et al. ,2004; Jang et al., 2003). Both extracts have also 
been reported to strongly inhibit the kinase activity of ERK which result in the inactivation of 
transcription factors AP-1 and CREB known to regulate COX-2 expression in mouse skin 
(Kundu et al., 2005). Chicory extract and EGCG, a green tea derived polyphenol produced a 
marked inhibition of PGE2 production in human colon carcinoma HT 29 cells which correlated 
to the inhibition of COX-2 expression mediated by the inhibition of NF-κB and AMP-activated 
protein kinase respectively (Cavin et al., 2005, Hwang et al., 2007). Therefore the control of 
COX-2 expression by plant phytochemicals constitutes a promising avenue for chemoprevention. 
 
  
Table 2. List of anti-inflammatory phytochemicals with putative chemopreventive potential in 
vitro and in vivo. 
Phytochemical compound Potential target Putative sites of blockade by 
anti-inflammatory 
phytochemical 
Reference 
(+)-Epigallocatechin gallate Proinflammatory 
mediators 
Downregulate 
proinflammatory mediators 
e.g. TNF-α, IL-8, PGE2 
Yang et al. (1998), Park et al. (2004), Abe et 
al. (1999), Trompezinski et al. 
(2003), Wheeler et al. (2004), Martinez and 
Moreno (2000), Michaluart et al. 
(1999), Matsuda et al. (2000), Onoda and 
Inano (2000), Kang et al. (2005) 
Capsaicin 
Curcumin 
Caffeic acid phenyl ester (CAPE) 
Resveratrol 
Soybean saponins 
Resveratrol, gingerol, CAPE 
curcumin, capsaicin, EGCG, 
soybean saponins, 
yakuchinones, ginsenosides 
Proinflammatory 
enzymes COX-2 
Downregulate the expression 
of COX-2 mRNA 
transcripts 
Kang et al. (2005), Martinez and Moreno 
(2000), Murakami et al. (2003), Michaluart 
et al. (1999), Kim et al., 2004b, Kim et al., 
2004c, Li et al. (2002), Yadav et al. (2003)  
Prevent mobilization of 
arachidonic acid and 
decrease PGE2 production 
Lee et al., 2004a, Lee et al., 2004b, Martinez 
and Moreno (2000) 
Capsaicin, CAPE Proinflammatory 
enzymes 
Decrease the transcriptional 
activity of iNOS and reduce 
NO• production 
Chen et al. (2003), Song et al. (2002) 
iNOS 
  
Resveratrol, gingerol, capsaicin, 
ginsenosides 
Nf-κB, AP-1, β-
catenin 
Blocking phosphorylation and 
degradation of IκBα 
Cho et al. (2002), Tsai et al. (1999), Kim et 
al., 2004a, Kim et al., 2004b, Han et al. 
(2001), Lee et al., 2004a, Lee et al., 2004b 
Suppressing phosphorylation 
and nuclear translocation of 
p65 
 
Blocking the activation of 
IKKα 
 
Downregulate β-catenin Manna et al. (2000)  
Adhami et al. (2003) 
Yakuchinones, ginsenosides Protein kinases Blocking ERK 
phosphorylation 
Yadav et al. (2003), Lee et al., 2004a, Lee et 
al., 2004b 
 
1.3. Targeting apoptotic regulatory pathways 
 
Apoptosis or programmed cell death has long been described as a key strategy for the 
elimination of neoplastic cells. This process is an important regulator of physiological growth 
control and regulation of tissue homeostasis in embryonic, fetal and adult tissues (Herr and 
Debatin, 2001). Apoptosis is characterized by typical morphological and biochemical hallmarks 
including cell shrinkage, chromatin condensation, nuclear DNA fragmentation, membrane 
blebbing and the formation of apoptotic bodies (Hengartner, 2000). Apoptosis can be triggered 
by two major pathways: (i) at the plasma membrane upon ligation of the death receptor (extrinsic 
pathway) and (ii) at the mitochondria (intrinsic pathway) (Hengartner, 2000). The stimulation of 
death receptors of the tumor necrosis factor (TNF) receptor superfamily such as CD95 (APO-
1/Fas) or TNF-related apoptosis-inducing ligand (TRAIL) receptors results in activation of the 
initiator caspase-8, which can propagate the apoptosis signal by direct cleavage of downstream 
effector caspases such as caspase-3 (Ashkenazi and Dixit, 1999). Ligation of the death receptors 
by their cognate ligands or agonistic antibodies results in receptor trimerization, clustering of the 
receptors’ death domains and recruitment of the adaptor molecules such as FADD through 
homophillic interaction mediated by the death domain (Fulda and Debatin, 2004, Kischkel et al., 
1995, Barnhart et al., 2003). FADD in turn recruits caspase-8 to the activated receptor to form 
the death-inducing signaling complex (DISC) and oligomerization of caspase-8 upon DISC 
formation drives its activation through self-cleavage. 
 
Caspases, a ubiquitous family of cysteine proteases play key roles both as upstream initiators and 
downstream effectors in apoptosis (Nicholson and Thornberry, 1997). This cascade leads to 
proteolytic cleavage of a variety of cytoplasmic and nuclear proteins, thereby favoring the 
prevalence of proapoptotic activities on antiapoptotic activities. The mitochondrial pathway is 
initiated by the release of apoptogenic factors such as cytochrome c, apoptosis-inducing factor 
(AIF), Smac/DIABLO, Omi/HtrA2, endonuclease G, caspase-2 or caspase-9 from the 
mitochondrial intermembrane space (Van Loo et al., 2002). The release of cytochrome c into the 
cytosol triggers caspase-3 activation through formation of the cytochrome c/Apaf-1/caspase-9-
containing apoptosome complex, while Smac/DIABLO and Omi/HtrA2 promote caspase 
activation through neutralizing the inhibitory effects to inhibitor of apoptotic proteins (IAPs) 
(Van Loo et al., 2002, Du et al., 2000). The selective induction of apoptosis in malignant and 
premalignant cells indicate a protective mechanism of both chemoprevention and chemoptherapy 
in carcinogenesis while enhancement of apoptosis is considered as a double-edged sword 
because of its potential implication in neuronal cell death in degenerative diseases (D’Agostini et 
al., 2005). 
 
Several mechanisms of apoptotic cell death have been proposed (Fulda and Debatin, 
2004, Cummings et al., 2004). Chemoprevention by targeting key components of the apoptosis 
regulatory pathways which include the antiapoptotic Bcl-2 family of proteins, the inhibitors of 
apoptosis (IAPs) in particular XIAP, cIAP1, cIAP2, survivin, nuclear factor-κB (NF-κB), 
caspases, tyrosine kinases and key signaling routes (the PI-3K/PKB pathway, the Stat3/5 
pathway and the MAPK pathway) (Hu et al., 2003, Juin et al., 2004, Lin and Karin, 
2003, Nakshatri and Goulet, 2002, Orlowski and Baldwin, 2002, Reed, 2003, Schimmer et al., 
2004, Stein and Waterfield, 2000, Workman, 2004) seems to be a rational approach in reducing 
the incidence of cancer. Bcl-2 or Bcl-XL exert their antiapoptotic function, at least in part, by 
sequestering BH3 domain only proteins in stable mitochondrial complexes, thereby preventing 
activation and translocation of proapoptotic proteins Bax or Bak to mitochondria (Cory and 
Adams, 2002). In addition, Bcl-2 and Bcl-XL block apoptosis by preventing 
cytochrome c release through a direct effect on mitochondrial channels such as the voltage-
dependent anion channel (VDAC) or the permeability transition pore complex (PTPC) (Cheng et 
al., 2003). Thus the Bcl-2 and the bcl-XL have emerged as a major new anticancer target. 
 
Another attractive cancer therapy is to trigger apoptosis in tumor cells via the death receptors in 
particular the tumor necrosis factor (TNF) receptor superfamily which includes CD95 and 
TRAIL receptors (Fulda and Debatin, 2004). Signaling through the death receptors induces 
apoptosis and chemopreventive agents and drugs can upregulate CD95 receptors and CD95 
ligands thereby stimulating the receptor pathway (Villunger et al., 1997). Moreover several 
anticancer agents have been reported to activate the CD95 pathway by modulating expression 
and recruitment of pro- or antiapoptotic components of the CD95 DISC to activated receptors 
(Fulda et al., 2001). Other modes of cell death including necrosis and autophagy (Leist and 
Jaattela, 2001) can also be considered as interesting target for chemoprevention. Thus a better 
understanding of the diverse modes of cell death in cancer therapy will provide a molecular basis 
for new strategies targeting death pathways. 
 
A wide range of putative cancer-chemopreventive plant extracts in particular Glycyrrhiza 
uralensis, Sologrum nigrum, Pereskia bleo, Cratoxylum cochinchinense, Rhodiola rosea, 
Physalis peruviana, Betulla platyphylla (Jo et al., 2005, Ju et al., 2004, Majewska et al., 
2006, Tan et al., 2005, Tang et al., 2004, Wu et al., 2004) has been suggested to induce apoptosis 
in neoplastic cells (Table 3). The apoptotic effect of the ethanolic extract of P. peruviana in 
human HepG2 cells resulted from the collapse of the mitochondrial membrane permeability and 
depletion of glutathione (Wu et al., 2004). Several authors have indicated that plant extracts can 
induce apoptosis via multiple mechanisms in particular by triggering the CD95–CD95L 
signaling pathway, activating the caspases, decreasing the expression of Bcl-2 and cyclin D1, 
upregulating p21 and proapoptotic protein Bax and by the MAPK activation that results in p53 
upregulation (Clement et al., 1998, Hu et al., 2002, She et al., 2001, She et al., 2002, Ju et al., 
2004). Literature data has indicated that apoptosis can be induced by the multitude of bioactive 
constituents in the herbal extracts. Organosulfur compounds, phenolic acids, resveratrol, 
flavonoids have been shown to induce apoptosis in a number of cancer cell lines (Majewska et 
al., 2006, Son et al., 2003, Tan et al., 2005, Tang et al., 2004). Resveratrol produced a significant 
induction of p21 expression that resulted in cell cycle blockade at the S phase and apoptosis 
induction in MCF-7 breast cancer cells (Pozo-Guisado et al., 2002). In addition, organosulfur 
compounds including ajoene, diallyl trisulfide, diallyl disulfide induced apoptosis through 
increased cytochrome c release, activation of caspase-3 and -8 and a decrease in Bcl-2 protein 
activity in a range of human derived cells (Lea et al., 1999, Lund et al., 2001, Tilli et al., 
2003, Sundaram and Milner, 1996, Xiao et al., 2004, Xiao and Singh, 2003). Recently Dave et 
al. (2005) showed that the isoflavone genistein prevented cancer by inducing apoptosis in target 
cell which coincided with increased PTEN expression both in vivo and in vitro. Another 
interesting target is the induction of TNF receptors mainly death receptor 4 (DR4) and death 
receptor 5 (DR5) which activate the apoptotic cascades. Curcumin enhanced TRAIL-induced 
apoptosis by significantly increasing DR5 expression both at its mRNA and protein levels (Jung 
et al., 2005). Moreover, Tsai et al. (2009) showed the in vivo efficacy of Wedelia chinensis, a 
common plant ingredient of Chinese herbal medicine in animals bearing a subcutaneous or 
orthotopic prostate cancer xenograft. The plant extract induced apoptosis selectively in androgen 
receptor-positive cancer cells and attenuated the growth of prostate tumors in nude mice 
implanted with a xenograft. These findings support the concept that inducers of apoptosis in 
neoplastic cells are of potential interest for rational drug design and several anticancer drugs that 
target apoptosis regulatory pathways are under clinical trials (Cummings et al., 2004). 
 
  
Table 3. The chemoprotective effect of plant extracts and their mechanism of action in cancer 
cell lines. 
Plant extracts with bioactive 
components 
Cell lines/animal 
models 
Mechanism of action Reference 
Sutherlandia frutescens (Cancer 
bush) and Harpagophylum 
procumbens (Devil's claw) 
Human mammary 
epithelial cells (MCF-
10A) stimulated with 
TPA 
Decreased COX-2 
expression by inhibiting 
DNA binding of AP-1 and 
NF-κB. 
Kundu et al. (2005), Na et al. (2004) 
 
ICR Mice (TPA 
induced COX-2 
expression in mouse 
skin) 
Inhibition of c-Fos 
expression and reduction 
of CREB DNA binding 
 
Trigonella foenum graecum Wistar rats (DMBA-
induced breast cancer) 
Induction of apoptosis Amin et al. (2005), Loo et al. 
(2004), Jo et al. (2005), Son et al. 
(2003), Tan et al. (2005), Tang et 
al. (2004), Ju et al. (2004) 
Herbal extracts (ginseng 
and Carthamus tinctorius) 
MDA-MB 231 human 
breast cancer cells 
  
Glycyrrhiza uralensis (Chinese 
licorice); Solanum nigrum L. 
MCF-7 human breast 
cancer cells 
  
Pereskia bleo T-47 D 
  
Cratoxylum cochinchinense Jurkat T cells 
  
Bettula platyphylla var japonica Human promyelocytic 
leukaemia (HL-60) 
  
Glycyrrhiza uralensis (Chinese 
licorice) 
MCF-7 human breast 
cancer cells 
G1 cell cycle arrest Jo et al. (2005) 
Ganoderma lucidum PC-3 human prostate 
cancer cell line 
Inhibit angiogenesis via the 
inactivation of AP-1 
resulting in down-
regulation of VEGF and 
TGF-β1 
Stanley et al. (2005), Neto et al. 
(2006) 
Vaccinium macrocarpon DU-145 prostate tumor 
cell line 
Decrease MMP-2 and 
MMP-9 expression 
 
Phellinus linteus; Psyllium extracts WB rat liver epithelial 
cells 
Modulation MAPK and 
downstream NF-κB and 
AP-1 
Cho et al. (2002), Nakamura et al. 
(2004) 
 
1.4. Cell cycle arrest in chemoprevention 
 
Cell cycle arrest occurs in response to cellular stress through activation of signal transduction 
pathways commonly referred to as checkpoints (Hartwell and Weinert, 1989). The checkpoints 
are activated in the G1/S phase to prevent replication of damaged DNA or in the G2/M phase to 
prevent segregation of damaged chromosomes during mitosis. Checkpoints ensure completion of 
phase-specific events and help maintain genetic integrity (Hartwell and Weinert, 1989). 
Increasing experimental data suggest that cell cycle control, particularly at the G1/S and G2/M 
transitions, represent a major task for the cell to ensure an accurate cell division. The 
carcinogenic process often affect progression through the S phase by inducing changes in 
expression and/or activity of cell cycle regulators thus offering a potential target for 
chemoprevention. The ethanolic extract of Chinese licorice root G. uralensis and downregulated 
CDK 2 and cyclin E and subsequently induced G1 cell cycle arrest in MCF-7 human breast 
cancer cell (Jo et al., 2005). Similar observations were made using eupatilin from Artemesia 
asiatica against MCF 10A-ras cells respectively (Kim et al., 2004b). This function can be 
attributed to the presence of secondary metabolites within the plant extract. A wide range of such 
phytochemicals have been reported to induce growth inhibition of cancer cells by interfering 
with their deregulated cell cycle progression through modulation of the expression and/or 
activities of key proteins including cyclin D1, cyclin B1, cdk2, cdc2, p53 and p27kip1. For 
instance the antiproliferative activity of the natural phytoalexin resveratrol was shown to result 
from the concentration-dependent inhibition in the expression of regulators of the G1/S transition 
of the cell cycle in particular cyclin D1, CDK4 and cyclin E in the MDA-MB-231 human breast 
cancer cells. In a similar fashion to the effects reported for the G1/S transition, resveratrol 
inhibited the expression of the G2/M regulators cdc2 and cyclin B1 (Pozo-Guisado et al., 2002). 
In addition an increase in the concentration of resveratrol induced a progressive decrease in the 
kinase activity of cyclin D1/CDK4 and cyclin B1/cdc2 complexes (Pozo-Guisado et al., 2002). 
Quercetin on the other hand exerts its anti-tumor effect through blocking cell cycle progression 
at the G0/G1 interface, consistent with Cdk inhibition while myricetin inhibited Cdk2 (Cragg and 
Newman, 2005). 
 
1.5. Angiogenesis: a potential target of chemoprevention 
 
Angiogenesis, the process of new blood vessel growth play a major role in tumor growth and 
metastasis. Thus, suppression of abnormal angiogenesis may provide strategies for halting the 
process of carcinogenesis (Ferrara and Kerbel, 2005). Part of the attraction of this approach is the 
near universality of its potential application, as essentially all cancers require a subsequent blood 
supply for their growth and their spread (Sawyers, 2004). A great deal of evidence suggests the 
antiangiogenic properties of a number of naturally derived phytochemicals (Cao et al., 2002, Oak 
et al., 2005, Stoclet et al., 2004). Tumor cells can produce potent angiogenic factors such as 
vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) and fibroblast 
growth factor-2 (FGF-2), which switch on an angiogenic phenotype of the tumor implant (Cross 
and Claesson-Welsh, 2001). The underlying mechanisms of a switch of angiogenesis phenotype 
in tumors are complex and often require upregulation of angiogenic factors and simultaneous 
down regulation of angiogenesis inhibitors. Therefore intervention of the angiogenic process 
seems to be a powerful approach for cancer therapy. The mechanistic insights of antiangiogenic 
compounds involve the inhibition of matrix metalloproteinases which block the degradation of 
the endothelial basement membrane, thereby preventing capillary sprout formation. Several of 
the chemopreventive agents can also prevent the angiogenic ligand/receptor mediated signaling 
pathways. 
 
Recent interest in extracts derived from food plants or medicinal herbs has gained significant 
recognition for their potential therapeutic uses in the inhibition of angiogenesis. The root extracts 
of Withania somnifera inhibited VEGF-induced angiogenesis in both the chickchorio-allantoic 
membrane and in mouse models (Mathur et al., 2006). Mechanistic insights into the potential 
effect of plant extracts included the modulation of MAPK and Akt signaling, inhibition of AP-1 
activation, and the down-regulation of VEGF and TGF-β1 (Stanley et al., 2005) which is largely 
due to the active ingredients within the extracts. Thus the effects of flavonoids mainly luteolin, 
genistein, apigenin, quercetin, fisetin in suppressing the growth of tumor cells have been reported 
(Fotsis et al., 1995, Fotsis et al., 1997). For instance EGCG target tissue plasminogen activator 
(t-PA), which is one of the critical proteases that enable tumors to metastasize (Jankun et al., 
1997). Moreover EGCG was found to directly inhibit capillary endothelial cell proliferation at 
low concentrations pointing out that the latter is an important angiogenesis inhibitor (Cao and 
Cao, 1999). The targets of EGCG seem not only to be limited to endothelial cells and their 
inhibition of angiogenesis may result from the inhibition of MMP-2 and MMP-9, as well as 
urokinase plasminogen activator (u-PA) at higher concentrations while a downregulation of 
VEGF production in tumor cells and subsequent repression of AP-1, NF-κB and STAT 1 
transcription factor pathways (Jung et al., 2001, Lin et al., 1999). 
 
The major antiangiogenic mechanisms of the natural phytochemicals (resveratrol, genistein, 
diadzein, apigenin) involve the down regulation of the angiogenic factors (MMP-9 and VEGF) 
as well as the upregulation of tissue inhibitor metalloproteinases (TIMP)-1 which lead to 
reduction of tumor cell invasion and blood vessel growth (Brakenhielm et al., 2001, Huang et al., 
1999, Tosetti et al., 2002). Another study showed the antiangiogenic effects of green tea extracts 
and its main catechin, EGCG in MDA-MB231 breast cancer cells and human umbilical vein 
endothelial cells. The extracts showed a significant decrease in VEGF peptide and this inhibition 
was regulated at the transcriptional level and accompanied by a significant decrease in VEGF 
promoter activity. The inhibition of VEGF formation correlated with the inhibition of protein 
kinase C and also c-fos and c-jun RNA transcripts, suggesting that activator protein (AP)-1-
responsive regions present in the human VEGF promoter may be involved in this inhibitory 
effect (Sartippour et al., 2002). In addition antioxidative effect of phytochemicals has recently 
been linked to antiangiogenesis. For instance, reduction of the oxidative stress by polyphenols 
leads to blockage of ROS formation and alterations in the cellular redox state, resulting in a 
reduced activation of transcription factors such as AP-1, p53 and NF-κB, which regulate the 
expression levels of the key angiogenic factors VEGF (Tosetti et al., 2002). This suggests the 
importance of antioxidant rich plant extracts (Table 1) or compounds in the management of 
angiogenesis as a key regulator in chemoprevention. 
 
1.6. Upregulation of gap junctional intercellular communication (GJIC) 
 
Another important target of chemoprevention involves the upregulation of gap junctional 
intercellular communication (GJIC). GJIC has been hypothesized to regulate growth, 
differentiation, apoptosis, wound healing and adaptive responses of differentiated cells 
(Loewenstein, 1990, Lucke et al., 1999, Wilson et al., 2000, Yamasaki and Naus, 1996). The gap 
junctions structure is transcribed and translated from a highly conserved family of genes coding 
for connexins which assembled into hexamers forming connexons which aligned with connexons 
of opposing contiguous cell membrane forming a channel for passive cytoplasmic diffusion of 
ions and other polarized and non-polarized molecules up to a molecular mass of 1 kDa which 
may set up gradients crucial in tissue growth and differentiation (Bruzzone et al., 1996, Kumar 
and Gilula, 1996). Data have shown that transfection of Cx32 or Cx43 gene into GJIC-defective 
and neoplastic cells resulted in GJIC restoration and reversion of the transformed phenotype 
(Omori et al., 1996, Rose et al., 1993) while dominant-negative mutant Cx43 transfected cell has 
been shown to inhibit GJIC and enhance tumorigenicity (Omori et al., 1996, Rose et al., 1993). 
Unlike the normal cells, neoplastic cells often elude this homeostatic control due to dysfunctional 
GJIC that could result mainly from non-expression of the connexin gene or from the non-
functional connexin proteins due to a mutation, abnormal splicing of message or modification by 
oncogenes and chemical tumor promoters (Trosko and Ruch, 2003). Tumor cells are therefore 
characterized by dysfunctional GJIC resulting in a lack of growth control by the inability to 
differentiate and by resistance to apoptosis (Hix et al., 2004). 
 
Various tumor promoters and oncogenes downregulate GJIC (Matesic et al., 1994) while several 
dietary factors and medicinal extracts have been suggested to modulate GJIC by induction of 
various signal transducing systems which can prevent inhibition of GJIC and therefore suppress 
tumorigenesis (Nielsen et al., 2000, Sigler and Ruch, 1993). Restoration of GJIC by natural 
compounds including CAPE, resveratrol, epicatechin, carotenoids, apigenin, tangeretin, 
ginsenoside Rb2 can be attributed to the upregulated expression of connexin 43 (CX43) protein 
and increased formation of Cx43 immunoreactive plaques in regions of the plasma membrane 
consistent with localization of gap junctions (Chaumontet et al., 1997, Hix et al., 2004, Na et al., 
2000, Nielsen et al., 2000, Kang et al., 2000). The activation of ERK1/2 and p38 kinase has been 
suggested as a primary mechanism of GJIC inhibition by various tumor promoters (Cho et al., 
2002). The intricate link between MAPK activation and inhibition of GJIC has been widely 
discussed (Cho et al., 2002), thus MAPK inhibitors are prospective therapeutic compounds 
against carcinogenesis. Plant extracts in particular Phellinus linteus and Psyllium extracts, have 
shown their efficacy in enhancing GJIC by targeting ERK1/2 and p38 kinase (Cho et al., 
2002, Nakamura et al., 2004). 
 
1.7. A unifying target: upstream kinases of intracellular signaling cascades and the downstream 
transcription factors 
 
A wide range of cytoplasmic protein kinases is important in relaying the events during cell signal 
transduction. In carcinogenesis, exogenous and endogenous stimuli affect the cell signaling 
network leading to activation and/or repression of upstream kinases thereby transmitting signals 
to the downstream targets. Cancer is characterized by aberrant and disrupted intracellular 
signaling networks (Shaw and Cantley, 2006), thus targeted inhibition of the protein kinases 
represent a rational approach in cancer chemoprevention. Several natural compounds including 
curcumin, flavonoids, genistein, luteolin, resveratrol, isothiocyanates, catechins, terpenoids and 
herbal/medicinal extracts have been identified to target components of the signal transduction 
pathways (Aggarwal and Shishodia, 2006, Huang et al., 2007, Hwang et al., 2005, Kundu and 
Surh, 2004, Lee et al., 2006, Lin et al., 1999) This makes them ideal components in maintaining 
the proper transmission of signal from receptors to effectors. Upstream components of the 
cytoplasmic signaling networks include the family of proline-directed serine/threonine kinases 
also referred to as the MAPKs, PKC, PI3K, protein kinase B/Akt, GSK and inappropriate 
upregulation of the above mentioned protein kinases transmit mitogenic signals to transcription 
factors, co-activators and co-repressors that result in the expression of cell proliferating genes. 
These pathways in turn regulate GJIC, the process of angiogenesis and the apoptotic regulatory 
network. 
 
Numerous intracellular signaling cascades converge with the activation of NF-κB, AP-1, c-myc, 
β-catenin which act independently or coordinately to regulate expression of target genes. These 
transcription factors mediate pleiotropic effects on cellular transformation and tumor promotion 
by transactivating several classes of target genes that have inflammatory, immunoregulatory, 
antiapoptotic and the cell cycle regulatory functions (Karin, 2006). Elevated levels of NF-κB 
have been detected in a number of human malignancies and the subsequent activation have been 
shown to suppress apoptosis, induce cellular transformation, proliferation, invasion, metastasis, 
chemo-resistance, radio-resistance and inflammation (Aggarwal and Shishodia, 2006). 
Suppressing the activity of these transcription factors by phenolic rich extracts would be 
expected to thwart the ability of cancer cells to thrive. Thus experimental data support the idea 
that transcription factors are the prime molecular targets of chemopreventive phytochemicals 
(Bode and Dong, 2004). The overexpression of the transcription factor NF-κB involved in 
multiple survival signaling pathways upregulate antiapoptotic proteins (Bcl-XL), XIAP and 
cIAP-2 suggesting NF-κB as a potential target for chemoprevention (Lin and Karin, 2003). 
Literature abounds in examples where plant extracts modulate the activation of protein kinases 
and transcription factors thereby interfering with carcinogenesis (Cavin et al., 2005, Kundu et al., 
2005) (Table 3). These cytoprotective effects have been ascribed to the naturally occurring 
secondary metabolites and experimental data have shown that resveratrol, EGCG, curcumin, 
apigenin, 1,4-dihydroquinone, flavan-3-ol derivatives, procyanidins, terpenoids interfere with the 
activation of NF-κB and AP-1 (Jeong et al., 2004, Kundu and Surh, 2004, Ma et al., 2003). The 
molecular mechanisms involved the blockade of phosphorylation and degradation of IκBα, 
thereby preventing the subsequent nuclear translocation (Cho et al., 2002, Tsai et al., 1999). 
Inhibitory effects on cell signaling molecules namely the MAPKs, NIK, IKK has been attributed 
for the subsequent inactivation of the transcription factors. Oligonol, a formulation of catechin 
type oligomers successfully inhibited 12-O tetradecanoylphorbol-13-acetate (TPA) induced 
COX-2 expression by blocking the activation of NF-κB and C/EBP via modulation of MAP 
kinases thereby suppressing mouse skin carcinogenesis (Kundu et al., 2009). The gallotannin 
penta 1,2,3,4,6-O-galloyl β-d-glucose inhibited DU145 xenograft growth in an athymic mouse 
model by inhibiting the activity pSTAT3 which in turn inhibit the expression of genes involved 
in cell survival (Hu et al., 2008). The promising therapeutic effect of cancer-chemopreventive 
agents on protein kinases is also an important strategy for the prevention of angiogenesis since 
activation of mitogen-activated protein kinase (MAPK) stimulates expression of VEGF, a key 
factor in angiogenesis (Milanini-Mongiat et al., 2002). Moreover inhibition of protein kinases 
may enhance the apoptotic pathway and the elimination of neoplastic cells as discussed above. 
 
2. Bioavailabilty and risk assessment of dietary polyphenols 
 
Despite numerous reports on the beneficial effects of polyphenols against a wide-spectrum of 
degenerative disorders, knowledge pertaining to bioavailability, pharmacokinetics, disposition 
and metabolic fate in humans is limited. However a number of human and animal studies have 
indicated the presence of phenolic compounds in the plasma and in specific tissues (Table 4). It 
is well known that absorption of polyphenols mainly of aglycones and anthocyanidins begins in 
the stomach (Passamonti et al., 2003) while pharmacokinetic data points to the absorption of 
both the aglycones and galloylated forms of flavonoids from the small intestine (Spencer et al., 
2000). In addition, the latter are metabolised to form methylated, glucuronidated or sulfated 
metabolites (Kay et al., 2005, Manach et al., 2005). A number of the polyphenolic classes in the 
main isoflavones, flavonols, flavanones, flavan-3-ols, phenolic acids and stilbenes have been 
shown to be absorbed sufficiently to exert their biological effects. The plasma kinetics of 
polyphenols differs among the polyphenolic classes depending on structural attributes with the 
maximum concentration being reached between 1.5 and 5.5 h depending on the site of intestinal 
absorption (Manach et al., 2005). Manach et al. (2005) reported that for the flavonoids-
epicatechin and genistein, a dose of 50 mg would give rise to a maximum plasma concentration 
from 0.4 μM (-epicatechin) to 2.5 μM (genistein). Almeida et al. (2009) reported the presence of 
trans-resveratrol in blood plasma of healthy adult volunteers following the administration of 25, 
50, 100 or 150 mg trans-resveratrol, six times/day with mean peak plasma concentration being 
3.89, 7.39, 23.1 and 63.8 ng/ml, 0.8–1.5 h postdose. The presence of phenolics constituents in 
the plasma and tissues can therefore improve the oxidant effects and prevents the disruption of 
cellular transduction pathways. 
 
Table 4. Bioavailaibility studies of anthocyanin, flavonols, flavanones, flavonols and isoflavones 
containing foods. Tmax: time to reach maximum concentration; bw: body weight; EGCG: 
epigallocatechin gallate; EGC: epigallocatechin; cyan-3-glc: cyanidin-3-glucoside. 
Source Class of 
phenolic or 
compound 
No. of 
subjects 
Dose Tmax plasma 
(h) 
Plasma 
concentration 
(nmol/L) 
Urinary 
excretion % of 
intake 
Reference 
Black currant 
juice 
Anthocyanin 17 20 or 12 mg total 
anth/kg bw 
0.75 32–107 0.045–0.072 Nielsen et al. 
(2003) 
Red fruit 
extract 
(1.6 g) 
Anthocyanin 12 2.7 mg cyan-3-glc/kg 
bw 
1 29 – Miyazawa et 
al. (1999) 
Onions Quercetin 5 186 mg quercetin eq 1.3–1.9 2180 1.11 Aziz et al. 
(1998) 
Pure quercetin Quercetin 12 0.14 mg/kg bw 0.5 150–420 2.9–7 Goldberg et 
al. (2003) 
Buckwheat tea Quercetin 12 200 mg quercetin eq 4.3 2.1 1 Graefe et al. 
(2001) 
Orange juice Flavanones 8 23 mg naringenin eq 5.5 0.64 1.1 Erlund et al. 
(2001) 
Grapefruit 
juice 
Flavanones 5 199 mg naringenin eq 4.8 5.99 30.2 Erlund et al. 
(2001) 
Cocoa Flavanols 6 1.53 mg/kg bw 2 1–1.5 – Schramm et 
al. (2003) 
Red wine 
(120 ml) 
Flavanols 9 35 mg catechin 1.44 0.077 – Bell et al. 
(2000) 
Green tea 
extracts 
Flavanols 8 2.8 mg EGCG/kg bw 1.6 0.17 EGCG Trace amount Lee et al. 
(1995) 
Black tea Flavanols 15 400 mg total catechins 
 
0.02 EGCG; 
0.14 EGC 
0.14 EGCG; 
0.14 EGC 
Warden et al. 
(2001) 
Soy beverage Isoflavones 12 0.6 mg diadzein/kg bw 5.5 0.3 – Shelnutt et 
al. (2002) 
 
Diet rich in flavanols and procyanidins can improve oxidant defense although these effects can 
be tissue specific. For instance, ellagic acid following pomegranate juice intake was detected in 
the plasma of all the human subjects studied with a maximum concentration of 
0.06 ± 0.01 μmol/L after 1 h while ellagic acid metabolites primarily total urolithin A and total 
urolithin B ranged between 0.14 and 0.01 μmol/L respectively at 6 h (Seeram et al., 2006). 
Another human intervention study showed the plasma pharmacokinetics of EGCG 
concentrations to range between 0.7 ± 0.4 and 0.5 ± 0.2 μmol/L after 2.5 h following intake of 
purified EGCG and green tea extract respectively. In addition the maximum plasma total 
flavanol (EGC, EC, EGCG, ECG) concentration after green tea extract intake was 3.2 μmol/L 
(Henning et al., 2005). Plasma epicatechin concentrations in Sprague–Dawley rats were also 
increased in a dose-dependent fashion following cocoa intake (128–790 nM) (Orozco et al., 
2003). 
 
Plant extracts/food biofactors with pharmacologic doses of polyphenols can therefore find 
applications in chemoprevention, however bioavailability and pharmacokinetics are vital for the 
design and interpretation of intervention studies and toxicologic testing may be required to 
ensure safe levels of intake. 
 
3. Conclusion 
 
Data derived from cancer cell lines, animal and clinical studies have indicated the potential role 
of targeting the disrupted cell signaling transduction pathways to intercept the relay of signals to 
downstream transcription factors and co-activators resulting in neoplastic transformation and cell 
proliferation. Moreover induction of phase II detoxifying enzymes, scavenging of ROS/RNS and 
induction of apoptosis represent an important strategy for the prevention of carcinogenesis. 
Plant-derived phytochemcials and plant extracts have been widely reported for their antioxidant 
properties, anti-inflammatory activities, upregulation of detoxifying enzymes and activation 
and/or repression of signal transduction pathways (Table 1, Table 2). Several independent studies 
have reported the beneficial effects of plant-derived phytochemicals and these compounds are 
mostly responsible for the protective properties of plant extracts. The potential synergistic effects 
of the myriad components in a plant extract may account for the protective effects against 
carcinogenesis. In addition, mixtures of interacting compounds produced by the plants may 
provide important combination therapies that simultaneously affect multiple pharmacological 
targets and can achieve clinical efficacy beyond the reach of single compound-based drugs while 
at the same time reducing the potential toxicity since much lower doses are sufficient. However, 
particular attention is mandatory before the potential application of these phytoceuticals in the 
management of cancer primarily in terms of (i) optimal dose, (ii) toxicity of the phytochemicals, 
(iii) metabolic conversion into pro-oxidant and cytotoxic components, (iv) interference with 
endogenous metabolic pathways, (v) interaction with other chemicals from the diet or drugs, (vi) 
induction of carcinogen activating enzymes and (vii) effects on human intestinal microflora 
should be assessed (Hodek et al., 2009). The bioavailability concerns that arise can only be 
resolved by future clinical trials which in addition will advance our understanding of the efficacy 
and safety of many chemopreventive phytoceuticals/extracts with therapeutic potential. Thus 
finding alternative/complementary approach in the prevention and treatment of carcinogenesis is 
of utmost significance. 
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